DURECT (DRRX) Insider Trading & Ownership $0.52 -0.04 (-6.84%) As of 07/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DURECT (NASDAQ:DRRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.20%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$79.01KNumber OfInsiders Selling(Last 3 Years)0 Get DRRX Insider Trade Alerts Want to know when executives and insiders are buying or selling DURECT stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DRRX Insider Buying and Selling by Quarter DURECT Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/19/2022Judith J RobertsonDirectorBuy9,412$0.85$8,000.20 8/17/2022Judith J RobertsonDirectorBuy10,189$0.85$8,660.65 8/11/2022Gail J MaderisDirectorBuy24,796$0.70$17,357.20 8/9/2022Gail J MaderisDirectorBuy70,307$0.64$44,996.48 (Data available from 1/1/2013 forward) DRRX Insider Trading Activity - Frequently Asked Questions Who is on DURECT's Insider Roster? The list of insiders at DURECT includes Gail J Maderis, and Judith J Robertson. Learn more on insiders at DRRX. What percentage of DURECT stock is owned by insiders? 3.20% of DURECT stock is owned by insiders. Learn more on DRRX's insider holdings. DURECT Key ExecutivesDr. James E. Brown D.V.M. (Age 67)Co-Founder, CEO, President & Director Compensation: $633.46kMr. Timothy M. Papp M.B.A. (Age 48)CFO & Secretary Compensation: $427.62kDr. Norman L. Sussman M.D. (Age 71)Chief Medical Officer Compensation: $471.71kMs. Judy R. Joice (Age 67)Senior Vice President of Operations & Corporate Quality Assurance Compensation: $451.82kDr. WeiQi Lin M.D.Ph.D., Executive VP of Research & Development and Principal ScientistMr. Keith L. Lui M.B.A.Senior Vice President of Business Development, Commercial & Medical AffairsMs. Jian Li M.B.A. (Age 54)Senior VP of Finance, Corporate Controller & Secretary Compensation: $297.08kDr. Su Il Yum Ph.D. (Age 85)Executive Officer Compensation: $331.74k More Insider Trading Tools from MarketBeat Related Companies VTGN Insider Trading RPTX Insider Trading IRD Insider Trading ANEB Insider Trading CNTX Insider Trading ASRT Insider Trading FBRX Insider Trading STRO Insider Trading CLSD Insider Trading MNOV Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, Buy This page (NASDAQ:DRRX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DURECT Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share DURECT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
